
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CEL-SCI (AMEX:CVM) through any online brokerage.
Other companies in CEL-SCI’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for CEL-SCI to provide a consensus price target.
The stock price for CEL-SCI (AMEX: CVM) is $1.76 last updated October 16, 2026 at 3:59 PM EDT.
There are no upcoming dividends for CEL-SCI.
CEL-SCI does not have any upcoming earnings scheduled.
There is no upcoming split for CEL-SCI.
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused...